Wednesday 14 October 2026
Export CVS’s income statement to Excel — free account
CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
87.65
0.09
−0.10%
Follow CVS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
56.28 | 12.23 | 12.46 | 29.31 | 17.19 | 12.46 | 14.60 | 0.00 | 11.35 | 16.27 |
Piotroski F-Score |
7 | 6 | 7 | 7 | 7 | 6 | 6 | 4 | 7 | 7 |
P/S ratio |
0.25 | 0.15 | 0.29 | 0.38 | 0.47 | 0.33 | 0.38 | 0.35 | 0.41 | 0.49 |
Altman Z-Score |
2.26 | 2.05 | 2.26 | 2.32 | 2.25 | 1.97 | 1.97 | 1.65 | 3.69 | 3.76 |
Altman Z″-Score (non-manufacturers) |
0.99 | 1.07 | 1.34 | 1.41 | 1.43 | 1.40 | 1.36 | 1.30 | 2.90 | 3.09 |
P/FCF ratio |
12.88 | 8.93 | 9.99 | 9.06 | 8.64 | 6.66 | 9.30 | 10.02 | 12.32 | 10.89 |
Beneish M-Score |
(2.64) | (2.61) | (2.34) | (2.62) | (2.60) | (2.58) | (2.62) | (2.45) | (2.47) | (2.72) |
P/Operating CF |
29.66 | 30.39 | (39.41) | (62.45) | 33.97 | 25.06 | 36.69 | 27.59 | (551.40) | 40.65 |
Dividend Safety Score |
43 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.33 | 0.75 | 1.36 | 1.70 | 1.81 | 1.28 | 1.51 | 1.17 | 1.99 | 2.34 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.38 | 0.30 | 0.43 | 0.49 | 0.62 | 0.53 | 0.61 | 0.70 | 0.54 | 0.62 |
EV/EBITDA |
10.31 | 8.53 | 8.51 | 13.01 | 9.86 | 7.80 | 9.60 | 10.49 | 8.21 | 8.58 |
EV/Operating CF |
14.52 | 12.28 | 11.47 | 9.79 | 9.84 | 9.03 | 12.23 | 15.26 | 12.51 | 10.88 |
EV/FCF |
19.79 | 17.67 | 14.82 | 11.78 | 11.41 | 10.66 | 15.12 | 19.81 | 16.45 | 13.93 |
Quick Ratio |
0.57 | 0.56 | 0.59 | 0.62 | 0.55 | 0.53 | 0.52 | 0.55 | 0.49 | 0.60 |
Current Ratio |
0.84 | 0.81 | 0.86 | 0.95 | 0.89 | 0.91 | 0.94 | 1.03 | 1.02 | 1.18 |
Net Debt/EBITDA |
3.60 | 4.22 | 2.77 | 3.00 | 2.39 | 2.93 | 3.69 | 5.19 | 2.07 | 1.87 |
Debt/Assets |
25.47% | 26.17% | 24.67% | 22.89% | 24.11% | 28.02% | 30.78% | 37.38% | 28.38% | 29.15% |
Debt/Equity |
0.86 | 0.88 | 0.80 | 0.73 | 0.75 | 0.93 | 1.07 | 1.25 | 0.72 | 0.75 |
Asset Turnover |
1.59 | 1.48 | 1.50 | 1.40 | 1.26 | 1.19 | 1.23 | 1.33 | 1.95 | 1.90 |
Operating CF/Net income |
6.02 | 1.97 | 1.61 | 3.75 | 2.28 | 2.21 | 1.94 | (14.92) | 1.21 | 1.91 |
Capex/Depreciation |
(0.27) | (0.60) | (0.69) | (0.65) | (0.51) | (0.55) | (0.56) | (0.23) | (0.72) | (0.90) |
Interest Coverage |
1.49 | 2.88 | 5.17 | 3.48 | 5.32 | 4.79 | 3.95 | 1.54 | 8.98 | 9.63 |
| 2.34% | 6.06% | 11.24% | 5.86% | 11.03% | 10.73% | 10.81% | (1.23%) | 17.77% | 14.36% | |
| 0.70% | 1.83% | 3.49% | 1.87% | 3.45% | 3.17% | 3.17% | (0.41%) | 6.99% | 5.69% | |
ROIC |
2.25% | 4.06% | 6.77% | 4.59% | 6.99% | 7.04% | 6.01% | 2.00% | 9.48% | 10.66% |
Return on Tangible Assets |
(197.54%) | (155.30%) | 450.54% | 47.45% | 156.97% | 103.18% | 73.36% | (4.72%) | 60.90% | 35.52% |
Average Days of Receivables |
36.11 | 35.71 | 35.94 | 30.87 | 30.53 | 29.53 | 27.89 | 33.07 | 26.04 | 25.01 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.44 | 0.47 | 0.48 | 0.45 | 0.46 | 0.48 | 0.51 | 0.59 | 0.55 | 0.55 |
Share Based Compensation of Revenue |
0.13% | 0.14% | 0.16% | 0.14% | 0.17% | 0.15% | 0.18% | 0.14% | 0.13% | 0.13% |
Graham Net Nets |
(1.03) | (1.93) | (1.01) | (0.75) | (0.72) | (1.17) | (1.12) | (1.35) | (0.35) | (0.31) |
Graham Number |
43.45 | 70.48 | 93.32 | 62.46 | 87.84 | 81.03 | 75.16 | 0.00 | 73.40 | 61.77 |
Earnings Yield |
1.78% | 8.18% | 8.03% | 3.41% | 5.82% | 8.02% | 6.85% | (0.84%) | 8.81% | 6.15% |
Free Cash Flow Yield |
7.76% | 11.19% | 10.01% | 11.03% | 11.57% | 15.02% | 10.75% | 9.98% | 8.12% | 9.18% |
Revenue per Share |
317.34 | 296.12 | 278.42 | 245.78 | 221.46 | 205.28 | 197.37 | 186.38 | 181.16 | 165.47 |
Operating CF per Share |
8.40 | 7.23 | 10.45 | 12.33 | 13.85 | 12.12 | 9.88 | 8.49 | 7.85 | 9.45 |
Capex per Share |
(2.24) | (2.21) | (2.36) | (2.08) | (1.91) | (1.86) | (1.89) | (1.95) | (1.88) | (2.07) |
Free Cash Flow per Share |
6.16 | 5.02 | 8.09 | 10.25 | 11.94 | 10.26 | 7.99 | 6.54 | 5.97 | 7.38 |
Cash per Share |
8.36 | 8.73 | 8.91 | 11.98 | 9.50 | 8.29 | 6.19 | 6.30 | 1.77 | 3.22 |
Shareholders Equity per Share |
59.50 | 60.15 | 59.64 | 54.70 | 57.15 | 53.25 | 49.32 | 56.08 | 36.96 | 34.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
59.50 | 60.15 | 59.64 | 54.70 | 57.15 | 53.25 | 49.32 | 56.08 | 36.96 | 34.33 |
Free Cash Flow |
7,807.00 | 6,326.00 | 10,395.00 | 13,450.00 | 15,745.00 | 13,428.00 | 10,391.00 | 6,828.00 | 6,089.00 | 7,917.00 |
Working Capital |
(13,978.00) | (15,964.00) | (11,331.00) | (3,788.00) | (7,799.00) | (5,648.00) | (3,001.00) | 1,234.00 | 581.00 | 4,792.00 |
Capital Expenditures |
(2,832.00) | (2,781.00) | (3,031.00) | (2,727.00) | (2,520.00) | (2,437.00) | (2,457.00) | (2,037.00) | (1,918.00) | (2,224.00) |
Net Current Asset Value |
(103,442.00) | (108,840.00) | (105,234.00) | (90,873.00) | (97,610.00) | (104,645.00) | (107,977.00) | (92,670.00) | (26,207.00) | (26,586.00) |
EV/EBIT |
33.16 | 13.13 | 11.21 | 19.92 | 13.50 | 10.29 | 13.10 | 33.64 | 10.50 | 10.62 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
21.58 | 6.64 | 7.56 | 15.33 | 10.22 | 6.43 | 8.06 | 17.01 | 7.86 | 8.30 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.79 | 0.35 | 0.33 | 0.33 | 0.38 | 0.35 | 0.36 | 0.78 | 0.26 | 0.24 |
Cash ROIC |
5.19% | 4.13% | 6.94% | 9.62% | 10.93% | 9.25% | 7.38% | 4.93% | 9.16% | 11.67% |
Accounts Receivable Turnover |
10.55 | 10.40 | 11.45 | 12.47 | 12.65 | 12.99 | 13.79 | 12.63 | 14.58 | 14.76 |
Accounts Payable Turnover |
13.19 | 13.40 | 14.60 | 14.38 | 14.85 | 15.16 | 16.35 | 17.59 | 18.26 | 18.99 |
Inventory Turnover |
11.84 | 11.42 | 11.70 | 10.69 | 9.70 | 9.11 | 9.35 | 9.86 | 10.21 | 10.19 |
Average Days of Payables |
29.11 | 28.12 | 25.05 | 27.51 | 26.04 | 24.79 | 24.13 | 20.82 | 21.08 | 19.79 |
Days of Inventory on Hand |
31.76 | 32.04 | 30.30 | 35.39 | 36.87 | 41.17 | 40.28 | 38.38 | 36.38 | 36.77 |
Average Receivables |
38,124.00 | 35,848.00 | 31,251.50 | 25,853.50 | 23,086.50 | 20,679.50 | 18,624.00 | 15,406.00 | 12,672.50 | 12,026.00 |
Average Payables |
16,766.50 | 15,394.50 | 14,867.50 | 13,691.00 | 11,841.00 | 10,815.00 | 9,708.50 | 8,894.00 | 8,404.50 | 7,718.00 |
Average Inventory |
18,676.50 | 18,066.00 | 18,557.50 | 18,425.00 | 18,128.00 | 18,006.00 | 16,983.00 | 15,873.00 | 15,028.00 | 14,380.50 |
Average Assets |
253,376.50 | 251,471.50 | 239,001.50 | 230,637.00 | 231,857.00 | 226,582.00 | 209,452.50 | 145,793.50 | 94,796.50 | 93,449.50 |
Average Common Equity |
75,556.00 | 76,183.00 | 74,202.50 | 73,575.00 | 72,541.00 | 66,935.50 | 61,356.50 | 48,119.00 | 37,264.50 | 37,018.50 |
Columns are period end dates